Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine lozenges for oral mucositis pain in allogeneic bone marrow transplant patients
2013-000343-11Phase 2Terminated
- Sponsor
- Clinical Research Malaysia
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bupivacaine + benzydamine in stomatitis, sponsored by Clinical Research Malaysia. Primary endpoint: VAS evaluation of oral pain. Started Apr 2013; status: terminated.
02
Drugs
bupivacaine + benzydamine
03
Conditions
stomatitis
Beyond the preview
Go deeper on 2013-000343-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000343-11.